Tes Pharma received FDA Orphan Drug Designation for TESP-0401 for the prevention of delayed graft function after renal transplantation.
Tes Pharma is a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal diseases, and metabolic diseases
Tes Pharma is a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal diseases, and metabolic diseases. The company utilizes a clinically validated drug discovery engine to generate rationally designed drug candidates for novel targets.